TIOMAX: A Spanish Multicenter Registry of the real-world use of the TItanium OptiMAX® biostent: TIOMAX: Registro Español Multicéntrico Del Biostent De Titanio OptiMAX® En La Vida Real.
Jose Ramon Lopez-MinguezJuan M Nogales-AsensioSebastián RomaniFernando Rivero-CrespoVictor M Aragón-ExtremeraJesús M Jiménez-MazuecosFernando CarrascoJuan Francisco Oteo-DomínguezFrancisco Bosa-OjedaJoan A Gómez-HospitalPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
The Titan Optimax retains the efficacy and safety of Titan 2. It appears to perform better in the subgroup of STEACS patients, by reducing the non-fatal CE of AMI/ST/TLR.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- acute myocardial infarction
- toll like receptor
- peritoneal dialysis
- inflammatory response
- immune response
- randomized controlled trial
- clinical trial
- heart failure
- coronary artery disease
- patient reported outcomes
- acute coronary syndrome
- study protocol
- open label
- energy transfer